XBI Stock Summary and Trading Ideas (SPDR Series Trust SPDR S&P Biotech ETF | ARCA:XBI)

The SPDR S&P Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index (the Index ). The S&P Biotechnology Select Industry represents the biotechnology segment of the S&P Total Market Index ( S&P TMI ). The S&P TMI is designed to track the broad U.S. equity market. The biotechnology segment of the S&P TMI comprises the Biotechnology sub-industry. The Index is modified equal weighted.

SPDR Series Trust SPDR S&P Biotech ETF trades on the ARCA stock market under the symbol XBI.

As of December 4, 2024, XBI stock price climbed to $98.65 with 4,471,920 million shares trading.

XBI has a beta of 1.32, meaning it tends to be more sensitive to market movements. XBI has a correlation of 0.32 to the broad based SPY ETF.

XBI has a market cap of $7.11 billion. This is considered a Mid Cap stock.

In the last 3 years, XBI traded as high as $119.21 and as low as $61.78.

XBI has underperformed the market in the last year with a return of +26.9%, while the SPY ETF gained +33.7%. In the last 3 month period, XBI fell short of the market, returning 0.0%, while SPY returned +10.2%. However, in the most recent 2 weeks XBI has outperformed the stock market by returning +5.9%, while SPY returned +2.8%.

XBI support price is $95.93 and resistance is $99.46 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XBI shares will trade within this expected range on the day.